Clinical Assessment of 177Lu-DOTATATE Quantification by Comparison of SUV-Based Parameters Measured on Both Post-PRRT SPECT/CT and 68Ga-DOTATOC PET/CT in Patients With Neuroendocrine Tumors
Philippe Thuillier, Meriem Maajem, Ulrike Schick, Frédérique Blanc-Béguin, Simon Hennebicq, Jean‐Philippe Metges, Pierre‐Yves Salaün, V. Kerlan, David Bourhis, Ronan Abgral
Abstract
Introduction The aim of this study was to study the feasibility of an SUV-based 177 Lu-DOTATATE SPECT/CT quantification and to assess the correlation of different parameters with the corresponding measured on 68 Ga-DOTATOC PET/CT in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors (WD-GEP-NET) treated with peptide receptor radionuclide therapy. Patients and Methods Patients with WD-GEP-NET who benefited from a pretherapeutic 68 Ga-DOTATOC PET/CT and a 177 Lu-DOTATATE SPECT/CT after the cycle 1 of peptide receptor radionuclide therapy were prospectively included. SPECT/CT acquisitions were performed on a system calibrated with a conversion factor of 9.48 counts/MBq per second and were reconstructed with an iterative algorithm allowing quantification using the SPECTRA Quant software (MIM Software, Cleveland, OH). For each patient, different SUV parameters were recorded on both PET/CT (Ga parameters) and SPECT/CT (Lu parameters) for comparison: physiological uptakes (liver/spleen), tumor uptake (1–10/patient; SUV max , SUV mean , SUV peak , MTV), tumor-to-liver and tumor-to-spleen ratios according to liver/spleen SUV max and SUV mean (TLR max , TLR mean , TSR max , and TSR mean , respectively). Results Ten patients (8 female; 2 male) aged from 50 to 83 years presenting with a metastatic progressive WD-GEP-NET (7 small intestine, 2 pancreas, 1 rectum) were included. Median values of lesional Lu-SUV were significantly lower than the corresponding Ga-SUV ( P < 0.001), whereas median values of lesional Lu-MTV, Lu-TLR, and Lu-TSR were significantly higher than the corresponding Ga-MTV, Ga-TLR, and Ga-TSR ( P < 0.02). Pearson correlation coefficients were strong for both SUV and MTV parameters (0.779–0.845), weak for TLR parameters (0.365–0.394), and moderate-to-strong for TSR parameters (0.676–0.750). Conclusions Our results suggest the feasibility of 177 Lu-DOTATATE SPECT/CT quantification in clinical practice and show a strong correlation of several SUV-based parameters with the corresponding in 68 Ga-DOTATOC PET/CT.